Definiendo el perfil del paciente candidato a 2 línea tras ITK

Cover

Table of Contents

Table of Contents

Previous Page

11 / 34

Next Page

Information

Previous Page

11 / 34

Next Page

Page Background

Treatment options in 2

nd

-3

rd

line

AXITINIB

NIVOLUMAB

CABOZANTINIB

LENVATINIB +

EVEROLIMUS

Rini B, et al .Lancet 2011

1 … 6 7 8 9 10 11 12 13 14 15 16 17 … 34 FlippingBook